NOTCH1 pathway activation contributes to the pathogenesis of over 60% of T-cell acute lymphoblastic leukemia (T-ALL). While Notch is thought to exert the majority of its effects through ...

Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...

Vancouver, BC, February 10, 2025-- (T-Net)-- Notch Therapeutics issued a statement recently indicating that the company is taking steps to preserve cash and explore alternative paths forward after ...